Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × peposertib × Clear all

NCT02516813 2024-10-15

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Phase 1 Completed

52 enrolled 43 charts

Other solid neoplasm

Advanced Solid Tumors